Gustav Silander

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition

Alisa Olkinuora, Taina T. Nieminen, Emma Mårtensson et al. · Genetics in Medicine · 2018 · 61 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Genetic anticipation in Swedish Lynch syndrome families

Jenny von Salomé, Philip S. Boonstra, Masoud Karimi et al. · PLoS Genetics · 2017 · 17 citations · Full text

Life Sciences, Genetics, Oncology +17

Disparities in colorectal cancer between Northern and SouthernSweden – a report from the new RISK North database

Gustav Silander, Ingvar Syk, Roger Henriksson et al. · Acta Oncologica · 2018 · 17 citations · Full text

Medicine, Demography, Oncology +17

A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families

Masoud Karimi, Jenny von Salomé, Christos Aravidis et al. · Hereditary Cancer in Clinical Practice · 2018 · 14 citations · Full text

Life Sciences, Genetics, Oncology +17